{"nct_id":"NCT02752074","title":"A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2016-06-21","start_date_type":"ACTUAL","primary_completion_date":"2018-01-08","primary_completion_date_type":"ACTUAL","completion_date":"2019-08-16","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["INCY"]}